Caplight Directory>Companies>TrianecT-preview>Trianect


TrianecT

TrianecT

Private
UtrechtHealthcare & Life Scienceshttps://trianect.com

Last Round

Seed

Jul 8, 2025

Total Funding Raised

$1.85M

Momentum Score

50 /100

Company Overview

TrianecT is a medical technology company that develops StrokePointer™, a device combining brain activity measurement and artificial intelligence to detect treatable stroke patients in ambulances.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Sensors, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

stroke detectionpre-hospital diagnosisportable EEGLVO detectionAI medical devicestroke triageemergency medical servicesEMSambulance technologydiagnostic AIbiosignal analysisdry EEGneurological diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TrianecT Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TrianecT Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 8, 2025
GrantDec 12, 2023
View all Funding Rounds

TrianecT Investors

Notable investors and investment history

InvestorRounds
CbusineZSeed
XO VenturesSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 207% MoM, from 483 to 1.5K.

  • Jul 8, 2025

    StrokePointer(TM), a portable stroke detection device, is accelerating market launch.

View all signals

TrianecT Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TrianecT Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TrianecT's valuation, stock price, and market status.

Firmographic Details

HeadquartersUtrecht
Employee Range10
Year Founded2022
Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.